Search Results

The Wako RF HA2 test is an in vitro diagnostic assay for the quantitative determination of rheumatoid factor activity in serum.

The Wako RF-HA(2) test is a highly specific reagent based on turbidimetric immunoassay. When the sample is mixed with Buffer and RF Reagent, rheumatoid factor in the sample combines specifically with the heat-aggregated human IgG in the reagents to yield an insoluble aggregate which causes increased turbidity in the solution. The degree of turbidity can be measured optically and is proportional to the amount of rheumatoid factor in the sample.

Here's a breakdown of the acceptance criteria and study information for the Wako RF-HA(2) test, based on the provided text:

Acceptance Criteria and Reported Device Performance

Study Details

2. Sample size used for the test set and the data provenance:

• The text does not explicitly state the sample size used for the correlation study.
• The data provenance (e.g., country of origin, retrospective/prospective) is not mentioned.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

• This information is not provided. The study compares the Wako RF-HA(2) against a predicate device, not directly against expert interpretations.

4. Adjudication method (e.g., 2+1, 3+1, none) for the test set:

• This information is not applicable/provided as the study focuses on a comparison to a predicate device rather than human adjudication of results.

5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

• No, an MRMC comparative effectiveness study was not performed. This device is an in vitro diagnostic assay, not an AI-assisted diagnostic tool for human readers.

6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:

• Yes, the study implicitly focuses on the standalone performance of the Wako RF-HA(2) test. It evaluates the assay's performance (correlation, regression, precision, minimum detectable level) as a direct measurement tool, without human intervention in the result generation or interpretation beyond routine lab procedures.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):

• The "ground truth" for this study is essentially the results obtained from the predicate device, Wako Autokit RF product. The comparison is between the new device and an established, legally marketed device.

8. The sample size for the training set:

• The text does not mention a separate training set or its sample size. This type of diagnostic assay typically does not involve a "training set" in the machine learning sense. The evaluation is of the finalized assay itself.

9. How the ground truth for the training set was established:

• As there's no mention of a training set, the establishment of "ground truth" for it is not applicable. The comparison is against the predicate device.

Ask a specific question about this device